With the help of its legislature and four successive governors, Connecticut has become a key hub for bioscience. Google the word “CT biotech” and the number of recent news articles about successful ...

The House of Representatives just passed a resolution condemning the “horrors of socialism” by a 285 to 98 margin. All the no votes were cast by Democrats indicating that a majority of the members ...

Earlier this year, Sen. Josh Hawley, R-Missouri, correctly noted that “American economic superiority means cutting China off from American ingenuity and halting the subsidization of [Chinese Communist ...

It’s a rare day when two of music’s biggest rockers weigh in on public policy. But that’s exactly what happened ...

Whatever political opposition existed around restricting drug prices through government intervention — and there was quite a lot not so long ago — seems to have largely disappeared. In other words, ...

Simple and neat solutions are alluring but often wrong. A case in point is President Trump’s proposal to adopt a most favored nation (MFN) policy. The MFN sets Medicaid’s price for a drug at the ...

Approximately 3.2 million Americans suffering from cancer, heart disease, and other serious or life-threatening diseases benefit from home infusion therapy. As the name suggests, home infusion therapy ...

The Trump administration has done a good job with promoting a free-market approach in many of its policies. However, they have taken a completely different tact to reduce prescription drug prices in ...

Cancer survival rates are on the rise, according to the American Cancer Society's latest annual report. Seven in 10 patients now live five years or more after a cancer diagnosis. Since 1991, ...

For decades, America’s drug-price debate has centered on a fundamental tension: How do policymakers encourage expensive research and development, while ensuring that companies keep final prices ...

ABOUT THE AUTHOR: Allison Schrager is a Bloomberg Opinion columnist covering economics. A senior fellow at the Manhattan Institute, she is author of “An Economist Walks Into a Brothel: And Other ...